000 | 01859 a2200601 4500 | ||
---|---|---|---|
005 | 20250514222521.0 | ||
264 | 0 | _c20050707 | |
008 | 200507s 0 0 eng d | ||
022 | _a1351-0088 | ||
024 | 7 |
_a10.1677/erc.1.00876 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aBerruti, A | |
245 | 0 | 0 |
_aIndependent prognostic role of circulating chromogranin A in prostate cancer patients with hormone-refractory disease. _h[electronic resource] |
260 |
_bEndocrine-related cancer _cMar 2005 |
||
300 |
_a109-17 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 | _aAged, 80 and over |
650 | 0 | 4 |
_aAlbumins _xmetabolism |
650 | 0 | 4 |
_aAlkaline Phosphatase _xblood |
650 | 0 | 4 |
_aBiomarkers, Tumor _xblood |
650 | 0 | 4 |
_aBone Neoplasms _xblood |
650 | 0 | 4 | _aCell Differentiation |
650 | 0 | 4 | _aChromogranin A |
650 | 0 | 4 |
_aChromogranins _xblood |
650 | 0 | 4 |
_aHemoglobins _xmetabolism |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aL-Lactate Dehydrogenase _xblood |
650 | 0 | 4 |
_aLiver Neoplasms _xblood |
650 | 0 | 4 |
_aLung Neoplasms _xblood |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aNeoplasm Staging |
650 | 0 | 4 |
_aNeoplasms, Hormone-Dependent _xblood |
650 | 0 | 4 | _aPrognosis |
650 | 0 | 4 | _aProspective Studies |
650 | 0 | 4 |
_aProstate-Specific Antigen _xblood |
650 | 0 | 4 |
_aProstatic Neoplasms _xblood |
650 | 0 | 4 | _aSurvival Rate |
700 | 1 | _aMosca, A | |
700 | 1 | _aTucci, M | |
700 | 1 | _aTerrone, C | |
700 | 1 | _aTorta, M | |
700 | 1 | _aTarabuzzi, R | |
700 | 1 | _aRusso, L | |
700 | 1 | _aCracco, C | |
700 | 1 | _aBollito, E | |
700 | 1 | _aScarpa, R M | |
700 | 1 | _aAngeli, A | |
700 | 1 | _aDogliotti, L | |
773 | 0 |
_tEndocrine-related cancer _gvol. 12 _gno. 1 _gp. 109-17 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1677/erc.1.00876 _zAvailable from publisher's website |
999 |
_c15459648 _d15459648 |